Application of the comet assay in human biomonitoring: An hCOMET perspective.


Journal

Mutation research. Reviews in mutation research
ISSN: 1388-2139
Titre abrégé: Mutat Res Rev Mutat Res
Pays: Netherlands
ID NLM: 101632211

Informations de publication

Date de publication:
Historique:
received: 01 07 2019
revised: 29 10 2019
accepted: 07 11 2019
entrez: 21 3 2020
pubmed: 21 3 2020
medline: 10 7 2020
Statut: ppublish

Résumé

The comet assay is a well-accepted biomonitoring tool to examine the effect of dietary, lifestyle, environmental and occupational exposure on levels of DNA damage in human cells. With such a wide range of determinants for DNA damage levels, it becomes challenging to deal with confounding and certain factors are inter-related (e.g. poor nutritional intake may correlate with smoking status). This review describes the effect of intrinsic (i.e. sex, age, tobacco smoking, occupational exposure and obesity) and extrinsic (season, environmental exposures, diet, physical activity and alcohol consumption) factors on the level of DNA damage measured by the standard or enzyme-modified comet assay. Although each factor influences at least one comet assay endpoint, the collective evidence does not indicate single factors have a large impact. Thus, controlling for confounding may be necessary in a biomonitoring study, but none of the factors is strong enough to be regarded a priori as a confounder. Controlling for confounding in the comet assay requires a case-by-case approach. Inter-laboratory variation in levels of DNA damage and to some extent also reproducibility in biomonitoring studies are issues that have haunted the users of the comet assay for years. Procedures to collect specimens, and their storage, are not standardized. Likewise, statistical issues related to both sample-size calculation (before sampling of specimens) and statistical analysis of the results vary between studies. This review gives guidance to statistical analysis of the typically complex exposure, co-variate, and effect relationships in human biomonitoring studies.

Identifiants

pubmed: 32192646
pii: S1383-5742(19)30045-6
doi: 10.1016/j.mrrev.2019.108288
pii:
doi:

Substances chimiques

Escherichia coli Proteins 0
DNA-Formamidopyrimidine Glycosylase EC 3.2.2.23
DNA-formamidopyrimidine glycosylase, E coli EC 3.2.2.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108288

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Amaya Azqueta (A)

Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009 Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain.

Carina Ladeira (C)

H&TRC - Health & Technology Research Center, ESTeSL - Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal; Centro de Investigação e Estudos em Saúde Pública, Escola Nacional de Saúde Pública, ENSP, Universidade Nova de Lisboa, Portugal.

Lisa Giovannelli (L)

Dept. NEUROFARBA, Section Pharmacology and Toxicology, University of Florence, Florence, Italy.

Elisa Boutet-Robinet (E)

Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France.

Stefano Bonassi (S)

Unit of Clinical and Molecular Epidemiology IRCCS San Raffaele Pisana, Rome, Italy; Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy.

Monica Neri (M)

Unit of Clinical and Molecular Epidemiology IRCCS San Raffaele Pisana, Rome, Italy.

Goran Gajski (G)

Mutagenesis Unit, Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, 10000 Zagreb, Croatia.

Susan Duthie (S)

School of Pharmacy and Life Sciences, The Robert Gordon University, Riverside East, Garthdee Road, Aberdeen AB10 7GJ, United Kingdom.

Cristian Del Bo' (C)

Università degli Studi di Milano, Department of Food, Environmental and Nutritional Sciences (DeFENS), Division of Human Nutrition, Via G. Celoria 2, 20133 Milano, Italy.

Patrizia Riso (P)

Università degli Studi di Milano, Department of Food, Environmental and Nutritional Sciences (DeFENS), Division of Human Nutrition, Via G. Celoria 2, 20133 Milano, Italy.

Gudrun Koppen (G)

VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium.

Nursen Basaran (N)

Hacettepe University, Faculty of Pharmacy, Department of Toxicology, 06100 Ankara, Turkey.

Andrew Collins (A)

Department of Nutrition, Institute for Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372 Oslo, Norway.

Peter Møller (P)

Department of Public Health, Section of Environmental Health, University of Copenhagen, DK-1014 Copenhagen K, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH